SION
Sionna Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$4.01
+3.08%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-36.6%
Return on equity
-34.4%
Return on assets
-40.0%
Return on invested capital
0.00x
Asset turnover
-$97.8M
Cash from operations
$4.67
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026